Page last updated: 2024-11-07

beta-aspartyl phosphate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-phospho-L-aspartic acid : The 4-phospho derivative of L-aspartic acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

4-phospho-L-aspartate : An L-alpha-amino acid anion arsing from deprotonation of the carboxy and phosphate OH groups of 4-phospho-L-aspartic acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID152441
CHEBI ID15836
SCHEMBL ID60233
MeSH IDM0100600

Synonyms (30)

Synonym
CHEBI:15836
l-beta-aspartyl dihydrogen phosphate
l-aspart-4-yl phosphate
(2s)-2-amino-4-oxo-4-(phosphonooxy)butanoic acid
4-phospho-l-aspartic acid
4-oxo-o-phosphono-l-homoserine
aspartic acid, 4-monoanhydride with phosphoric acid, l-
l-aspartic acid, 4-monoanhydride with phosphoric acid (9ci)
l-homoserine, 4-oxo-o-phosphono-
beta-l-aspartyl phosphate
l-aspartyl beta-phosphate
aspartic acid, 4-monoanhydride with phosphoric acid, l- (8ci)
phosphoric acid, 4-monoanhydride with aspartic acid, l-
l-aspartic acid, 4-monoanhydride with phosphoric acid
beta-aspartyl phosphate
l-aspartyl-4-p
22138-53-0
4-phospho-l-aspartate
l-4-aspartyl phosphate
C03082
DB01857
phosphoaspartate
aspartyl phosphate
(2s)-2-amino-4-oxo-4-phosphonooxybutanoic acid
SCHEMBL60233
4-phosphoaspartic acid
l-b-aspartyl-phosphate
l-aspartyl-b-phosphate
l-b-aspartyl-p
Q27092984
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
Escherichia coli metaboliteAny bacterial metabolite produced during a metabolic reaction in Escherichia coli.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
aminoacyl phosphate
L-aspartic acid derivativeA proteinogenic amino acid derivative resulting from reaction of L-aspartic acid at the amino group or either of the carboxy groups, or from the replacement of any hydrogen of L-aspartic acid by a heteroatom.
non-proteinogenic L-alpha-amino acidAny L-alpha-amino acid which is not a member of the group of 23 proteinogenic amino acids.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (8)

PathwayProteinsCompounds
superpathway of lysine, threonine and methionine biosynthesis II032
isoleucine biosynthesis I024
superpathway of lysine, threonine and methionine biosynthesis I038
threonine biosynthesis016
lysine biosynthesis VI019
lysine biosynthesis I024
Threonine biosynthesis07
Homoserine biosynthesis010
Lysine biosynthesis I224
Lysine biosynthesis II226
Lysine biosynthesis VI319

Research

Studies (24)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (25.00)18.7374
1990's2 (8.33)18.2507
2000's11 (45.83)29.6817
2010's5 (20.83)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.74

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.74 (24.57)
Research Supply Index3.22 (2.92)
Research Growth Index4.96 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.74)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (8.33%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other22 (91.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]